Updated on 2025/06/17

Information

 

写真a

 
TAKAYAMA KOJI
 
Organization
Kyushu University Hospital General Internal Medicine Assistant Professor
School of Medicine Department of Medicine(Concurrent)
Title
Assistant Professor
Profile
総合診療科外来で内科系の外来診療(初診、再診)に従事している。また総合診療科病棟では入院患者の主治医として診療および研修医の指導を行う一方で、病棟医長として科全体の入院患者の統括的な診療やベッドコントロールの業務を行っている。2020年度からはCOVID-19患者の救急対応および入院診療に携わっている。またグローバル感染症センターの委員として院内感染対策業務も行っている。研究については、生活習慣病や感染症に関する臨床研究を行い、研究成果の論文発表や学会発表を行っている。教育については、医学部医学科学生のを対象とした講義、臨床実習指導、症例発表指導を担当している。社会連携については、沖縄県石垣市、福岡県粕屋町などの地域自治体と協力して住民健診を行い、地域住民の健康維持の活動に参加している。
External link

Degree

  • Ph. D

Research Interests・Research Keywords

  • Research theme: Epidemiological study of lifestyle diseases / infectious diseases in the general population

    Keyword: epidemiology, lifestyle diseases, infectious diseases

    Research period: 2017.4

  • Research theme: Epidemiological study of lifestyle diseases / infectious diseases in the general population

    Keyword: epidemiology, lifestyle diseases, infectious diseases

    Research period: 2017.4

Papers

  • Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality

    Danzuka, Y; Nakamura, K; Matsumoto, S; Etoh, Y; Yamasaki, S; Takayama, K; Murata, M; Shimono, N

    JOURNAL OF INFECTION AND CHEMOTHERAPY   31 ( 7 )   102737   2025.7   ISSN:1341-321X eISSN:1437-7780

     More details

    Language:English   Publisher:Journal of Infection and Chemotherapy  

    A 71-year-old female with post-treatment follicular lymphoma developed COVID-19 with persistent viremia. Despite the initiation of remdesivir on day 23, she remained SARS-CoV-2 PCR-positive and ultimately succumbed to respiratory failure on day 79. Whole-genome analysis of RNA extracted from a post-mortem nasopharyngeal swab identified multiple mutations, including P323L/G671S, which enhances viral replication, and V792I, associated with remdesivir resistance. This case highlights the challenges of managing persistent SARS-CoV-2 infection in immunocompromised patients and underscores the impact of delayed treatment and antiviral resistance.

    DOI: 10.1016/j.jiac.2025.102737

    Web of Science

    Scopus

    PubMed

  • Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study

    Ikezaki H., Nakashima R., Matsumoto Y., Ohta A., Yamasaki S., Hiramine S., Takayama K., Ogawa E., Murata M., Furusyo N., Hayashi J., Shimono N., Schaefer E.J.

    Atherosclerosis Plus   59   10 - 17   2025.3   ISSN:26670909

     More details

    Language:English   Publisher:Atherosclerosis Plus  

    Background and aims: The prevalence of metabolic dysfunction associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), has become a significant public health concern with an increased atherosclerotic cardiovascular disease risk. This study investigates the impact of NAFLD-related single nucleotide polymorphisms (SNPs) on carotid atherosclerosis development in a Japanese population without diabetes, dyslipidemia, and hypertension. Methods: The prospective observational study, part of the Kyushu and Okinawa Population Study (KOPS), included 945 participants (median age 55 [47, 63]) without carotid atherosclerosis, increased alcohol intake, diabetes, dyslipidemia, hypertension, or chronic hepatitis at baseline. NAFLD-related SNPs (GCKR, NCAN, and PNPLA3) were genotyped, and carotid intima-media thickness (cIMT) was measured using ultrasonography. Univariate and multivariate regression analyses were performed to assess the association of NAFLD-related SNPs on newly developed carotid atherosclerosis over five years. Results: After five years, 125 (13.2 %) participants developed carotid atherosclerosis. The NCAN (rs2228603) T allele was associated with a lower incidence rate of carotid atherosclerosis (4.7 % in NCAN CT/TT genotype vs. 13.9 % in CC genotype; p = 0.04), and NCAN T allele carriers exhibited a favorable lipid profile. These associations were not altered by either recruiting area or obese. The GCKR T allele and PNPLA3 C allele were associated with low carotid atherosclerosis development rates but were not significant. Conclusions: Our results suggested that some NAFLD-related SNPs may influence atherosclerosis through lipid metabolism among Japanese individuals without metabolic syndrome.

    DOI: 10.1016/j.athplu.2024.12.003

    Scopus

    PubMed

  • A case of mediastinal abscess and infected aortic aneurysm caused by dissemination of Mycobacterium abscessus subsp. massiliense pulmonary disease

    Matsumoto, Y; Murata, M; Takayama, K; Yamasaki, S; Hiramine, S; Toyoda, K; Kibe, Y; Nishida, R; Kimura, S; Sonoda, H; Shiose, A; Shimono, N

    JOURNAL OF INFECTION AND CHEMOTHERAPY   29 ( 1 )   82 - 86   2023.1   ISSN:1341-321X eISSN:1437-7780

     More details

    Language:English   Publisher:Journal of Infection and Chemotherapy  

    An 81-year-old man was admitted to our hospital because of fever and malaise that had persisted for 3 months. The patient had undergone two aortic valve replacements, 10 and 5 years previously, because of aortic valve regurgitation and infectious endocarditis. He also had had asymptomatic Mycobacterium abscessus complex (MABC) pulmonary disease for the two previous years. Contrast-enhanced computed tomography showed a mediastinal abscess and an ascending aortic aneurysm. Mycobacterium abscessus subsp. massiliense was cultured from his blood, suggesting the aortic aneurysm was secondary to infection of an implanted device. After enlargement over only a few days, a leakage of contrast medium to the mediastinal abscess was found on computed tomography. The patient was diagnosed with rupture of an infectious aortic aneurysm, and emergency aortic replacement and drainage of the mediastinal abscess were successful. The patient was treated with several antibiotics, including meropenem, amikacin, and clarithromycin, and his general condition improved. Cultures from both the mediastinal abscess and a pericardial patch that was placed at the time of surgery 5 years previously revealed MABC. In our case, the infected aortic aneurysm most likely resulted from MABC pulmonary disease rather than from previous intraoperative contamination. This route of infection is rare. Physicians should be aware of the possibility of dissemination and subsequent infection of implants related to MABC pulmonary disease.

    DOI: 10.1016/j.jiac.2022.09.017

    Web of Science

    Scopus

    PubMed

  • 肺Mycobacterium abscessus subsp. massiliense症の播種に起因する縦隔膿瘍と感染性動脈瘤の1症例(A case of mediastinal abscess and infected aortic aneurysm caused by dissemination of Mycobacterium abscessus subsp. massiliense pulmonary disease)

    Matsumoto Yuji, Murata Masayuki, Takayama Koji, Yamasaki Sho, Hiramine Satoshi, Toyoda Kazuhiro, Kibe Yasushi, Nishida Ruriko, Kimura Satoshi, Sonoda Hiromichi, Shiose Akira, Shimono Nobuyuki

    Journal of Infection and Chemotherapy   29 ( 1 )   82 - 86   2023.1   ISSN:1341-321X

     More details

    Language:English   Publisher:エルゼビア・ジャパン(株)  

    症例は81歳男性で、発熱と倦怠感を主訴に当院紹介となった。患者は10年前に大動脈弁逆流症による大動脈弁置換術、5年前に感染性心内膜炎による2回目の大動脈弁置換術を受け、同時に胃癌と診断され幽門側胃切除術を受けていた。2年前に肺NTM症と診断されていた。入院時の全身の外観はわずかに不良で肩と膝の関節痛を訴えていた。表在リンパ節は触診できなかった。血清アルブミン値の減少とCRP値の軽度上昇がみられた。9ヵ月前の胃癌フォローアップ造影CT検査で大動脈弁近傍の液体貯留が示されたが、無症状のため精密検査は実施されなかった。入院5日後に実施された造影CTで前縦隔内のリング状増強低密度領域、低密度領域近くの上行大動脈の偽動脈瘤、両側胸膜液が示された。右側胸膜液の穿刺により漏出性胸水が認められたが培養でNTMは検出されなかった。感染性大動脈瘤と縦隔膿瘍が示唆されたためバンコマイシンとメロペネムを投与した。血液培養で分離された抗酸菌は迅速発育菌であったためメロペネム/アミカシン/クラリスロマイシンに切り替えた。感染性動脈瘤破裂が認められ、緊急の大動脈置換術と縦隔膿瘍ドレナージを実施した。縦隔膿瘍と心膜パッチからMycobacterium abscessus subsp. massilienseが分離された。3剤治療により術後CRP値は低下し血液培養は陰性となり、2ヵ月後リハビリ病院へ転院した。

  • A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy

    Sasaki, K; Murata, M; Nakamura, K; Matsumoto, Y; Nakashima, Y; Yamasaki, S; Ota, A; Hiramine, S; Takayama, K; Ikezaki, H; Toyoda, K; Ogawa, E; Shimono, N

    JOURNAL OF INFECTION AND CHEMOTHERAPY   28 ( 8 )   1208 - 1211   2022.8   ISSN:1341-321X eISSN:1437-7780

     More details

    Language:English   Publisher:Journal of Infection and Chemotherapy  

    A 53-year-old male Japanese patient with COVID-19 was admitted to our hospital after his respiratory condition worsened on day 9 of the disease. With the diagnosis of severe COVID-19, treatment with remdesivir, dexamethasone, and unfractionated heparin was started for the prevention of thrombosis. Although the patient's respiratory status data improved after treatment, severe respiratory failure persisted. Thrombocytopenia and D-dimer elevation were observed on day 8 after heparin therapy initiation. Heparin-induced thrombocytopenia (HIT) antibody measured by immunological assay was positive, and contrast computed tomography showed pulmonary artery thrombus. The patient was diagnosed with HIT because the pre-test probability score (4Ts score) for HIT was 7 points. Heparin was changed to apixaban, a direct oral anticoagulant, which resulted in a reduction of the pulmonary thrombus and improvement of the respiratory failure. In patients with COVID-19, anticoagulant therapy with heparin requires careful monitoring of thrombocytopenia and elevated D-dimer as possible complications related to HIT. (151/250 words).

    DOI: 10.1016/j.jiac.2022.05.001

    Web of Science

    Scopus

    PubMed

  • 予防的抗凝固療法中のヘパリン起因性血小板減少症に関連する肺血栓塞栓症の重症COVID-19の1例(A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy)

    Sasaki Kosaku, Murata Masayuki, Nakamura Keiji, Matsumoto Yuji, Nakashima Yuko, Yamasaki Sho, Ota Azusa, Hiramine Satoshi, Takayama Koji, Ikezaki Hiroaki, Toyoda Kazuhiro, Ogawa Eiichi, Shimono Nobuyuki

    Journal of Infection and Chemotherapy   28 ( 8 )   1208 - 1211   2022.8   ISSN:1341-321X

     More details

    Language:English   Publisher:エルゼビア・ジャパン(株)  

    症例は53歳男性で、発熱と全身倦怠感を呈し、抗原検査でSARS-CoV-2陽性と判定された。軽症患者向けの施設に滞在していたが、低酸素症が進行したため当院へ搬送された。酸素飽和度は85%で、両側下肺野で捻髪音が聴取された。血液検査ではAST、ALT、LDH、フィブリノゲン、CRP値の上昇がみられた。胸部X線では両肺野にすりガラス陰影が示された。レムデシビルとデキサメタゾン治療を開始し、予防的抗凝固療法として非分画ヘパリン(UFH)の静脈内持続点滴を開始した。細菌の同時感染に対するセフトリアキソンとアジスロマイシンも投与した。入院から数時間のうちに低酸素症が悪化しリザーバーマスクから高流量鼻カニューレによる酸素サポートに切り替えた。治療4日目呼吸状態は改善されCRP値も低下し、8日目にリザーバーマスクに変えた。しかし、6日目にDダイマー値は上昇傾向を示し、結果的にUFH用量は増加した。血小板数は4日目に増加したが8日目に減少した。肺血栓塞栓症/ヘパリン起因性血小板減少症(HIT)を疑いラテックス免疫比濁アッセイを行った結果HIT抗体が陽性となった。造影CT画像で右肺動脈主幹部の血栓が示された。HITの4Tsスコアが7点となりHITと診断され、UFHをアピキサバンに変更した。26日目にDダイマー陰性となり33日目に退院した。最終的にアピキサバンは95日間投与された。

▼display all

Professional Memberships

  • 日本内科学会

  • 日本感染症学会

  • 日本病院総合診療医学会

  • 日本肝臓学会

Committee Memberships

  • 日本病院総合診療医学会   Councilor   Domestic

    2021.4 - Present   

Educational Activities

  • 医学部医学科5、6年生の臨床実習指導の担当、医学部医学科学生の客観的臨床能力試験(OSCE)の指導および評価の担当、医学部医学科学生の講義の担当

Class subject

  • 臨床実習I

    2024.4 - 2025.3   Full year

  • クリニカルクラークシップ

    2024.4 - 2024.9   First semester

  • 臨床実習I

    2023.4 - 2024.3   Full year

  • クリニカルクラークシップ

    2023.4 - 2023.9   First semester

  • 臨床実習I

    2022.4 - 2023.3   Full year

  • クリニカルクラークシップ

    2022.4 - 2022.9   First semester

  • 総合診療 悪性腫瘍のプライマリケア

    2021.10 - 2022.3   Second semester

  • 臨床実習I

    2021.4 - 2022.3   Full year

  • クリニカルクラークシップ

    2021.4 - 2021.9   First semester

  • 総合診療 悪性腫瘍のプライマリケア

    2020.10 - 2021.3   Second semester

  • 臨床実習I

    2020.4 - 2021.3   Full year

  • クリニカルクラークシップ

    2020.4 - 2020.9   First semester

  • 総合診療 悪性腫瘍のプライマリケア

    2019.10 - 2020.3   Second semester

  • 臨床実習I

    2019.4 - 2020.3   Full year

  • クリニカルクラークシップ

    2019.4 - 2019.9   First semester

  • 総合診療 悪性腫瘍のプライマリケア

    2018.10 - 2019.3   Second semester

  • 臨床実習I

    2018.4 - 2019.3   Full year

  • クリニカルクラークシップ

    2018.4 - 2018.9   First semester

  • 総合診療 悪性腫瘍のプライマリケア

    2017.10 - 2018.3   Second semester

▼display all

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Internal Medicine / General Internal Medicine (including psychosomatic medicine)

    総合診療

Clinician qualification

  • Specialist

    The Japanese Society of Internal Medicine(JSIM)

  • Specialist

    The Japan Society of Hepatology(JSH)

  • Infection Control Doctor

    The Japanese Association for Infectious Diseases

  • Preceptor

    日本病院総合診療医学会

Year of medical license acquisition

  • 2007

Notable Clinical Activities

  • 病棟医長および病棟主治医として入院診療を行っており、2020年度からはCOVID-19の救急対応・入院診療も行っている。いる。ほか週2日、外来診療(新患、再来)を行っている。またグローバル感染症センター委員として院内感染対策の業務に携わっており、2023年度からはICT/ASTメンバーとして感染症全般に対する院内コンサルタントを担当している。